BTX161 CAS No.2052301-24-1
BTX161 CAS No.2052301-24-1
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-4489 | 5mg | 530.00 | + Add to cart |
|
| R-R-4489 | 10mg | 880.00 | + Add to cart |
|
|
|
||||
Product description
BTX161/CAS No.2052301-24-1, a Thalidomide analog, is a potent CKIα degrader. BTX161 mediates degradation of CKIα better than Lenalidomide in human AML cells and activates DNA damage response (DDR) and p53, while stabilizing the p53 antagonist MDM2.
| Appearance | N/A |
|---|---|
| Molecular Weight | 272.30 |
| Purity | >90% |
| CAS | 2052301-24-1 |
| Formula | C15H16N2O3 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of BTX161 CAS No.2052301-24-1
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


